NDC 0009-7686

Caverject

Alprostadil

Caverject is a Intracavernous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Pharmacia And Upjohn Company Llc. The primary component is Alprostadil.

Product ID0009-7686_bcba81bc-8862-47b0-81fe-f84285f54036
NDC0009-7686
Product TypeHuman Prescription Drug
Proprietary NameCaverject
Generic NameAlprostadil
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRACAVERNOUS
Marketing Start Date1995-07-06
Marketing CategoryNDA / NDA
Application NumberNDA020379
Labeler NamePharmacia and Upjohn Company LLC
Substance NameALPROSTADIL
Active Ingredient Strength41 ug/mL
Pharm ClassesGenitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [CS],Venous Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0009-7686-04

6 VIAL, SINGLE-DOSE in 1 PACKAGE (0009-7686-04) > 1 mL in 1 VIAL, SINGLE-DOSE (0009-7686-01)
Marketing Start Date1995-07-06
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0009-7686-01 [00009768601]

Caverject INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA020379
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-03-09

NDC 0009-7686-04 [00009768604]

Caverject INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA020379
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1995-07-06

Drug Details

Active Ingredients

IngredientStrength
ALPROSTADIL41.1 ug/mL

OpenFDA Data

SPL SET ID:a295fc1e-d82c-4f44-bc2d-a552bf594c98
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 103956
  • 226922
  • 226921
  • 242691
  • Pharm Class PE
  • Genitourinary Arterial Vasodilation [PE]
  • Venous Vasodilation [PE]
  • PHarm Class EPC
  • Prostaglandin Analog [EPC]
  • Prostaglandin E1 Agonist [EPC]
  • NUI Code
  • N0000009059
  • N0000000106
  • N0000175454
  • N0000007706
  • N0000009911
  • N0000180189
  • Pharmacological Class

    • Genitourinary Arterial Vasodilation [PE]
    • Prostaglandin Analog [EPC]
    • Prostaglandin E1 Agonist [EPC]
    • Prostaglandin Receptor Agonists [MoA]
    • Prostaglandins [Chemical/Ingredient]
    • Venous Vasodilation [PE]
    • Prostaglandins [CS]
    • Genitourinary Arterial Vasodilation [PE]
    • Prostaglandin Analog [EPC]
    • Prostaglandin E1 Agonist [EPC]
    • Prostaglandin Receptor Agonists [MoA]
    • Prostaglandins [CS]
    • Venous Vasodilation [PE]

    NDC Crossover Matching brand name "Caverject" or generic name "Alprostadil"

    NDCBrand NameGeneric Name
    0009-3701CaverjectAlprostadil
    0009-7686CaverjectAlprostadil
    0703-1501AlprostadilAlprostadil
    0009-5181Caverject ImpulseAlprostadil
    0009-5182Caverject ImpulseAlprostadil
    63539-121Caverject ImpulseAlprostadil
    63539-221Caverject ImpulseAlprostadil
    52244-010Edexalprostadil
    52244-020Edexalprostadil
    52244-040Edexalprostadil
    0037-8110MUSEAlprostadil
    0037-8120MUSEAlprostadil
    0037-8130MUSEAlprostadil
    0037-8140MUSEAlprostadil
    0009-0215PROSTINalprostadil
    0009-3169PROSTINalprostadil

    Trademark Results [Caverject]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CAVERJECT
    CAVERJECT
    74329204 1835984 Live/Registered
    PHARMACIA & UPJOHN COMPANY LLC
    1992-11-06

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.